I have been working on transparency and levels of evidence of research in pancreatic adenocarcinoma.
Following my initial work, I am now focusing on the role of observational studies and evaluating how it challenges the current framework of evidence in medical research.
In parallel, I am also associated with the ESMO real-world and digital health working group where I work on several projects regarding real-world evidence in oncology. I am co-leading one of the projects.
Finally, as a medical doctor, I also work part-time in the digestive oncology department of the Cochin hospital in Paris, where I will then pursue my academic career at the end of my PhD.
Research interests
- digestive oncology
- real-world data
Key publications
- Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms.
Pellat A et al. Neuroendocrinology
- Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years.
Anna Pellat et al. Oncologist
Links
Theses
Transparency and levels of proof of interventional research on pancreatic cancer
Anna Pellat
Promotion : 2021 - 2024
Supervisor.s : Philippe Ravaud
